Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates

Authors:

Abstract
No abstract available

This publication has 48 references indexed in Scilit: